Alternatives to Somite.ai

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.